Literature DB >> 30245076

Clinical practice guideline. Diagnosis and prevention of colorectal cancer. 2018 Update.

Joaquín Cubiella1, Mercè Marzo-Castillejo2, Juan José Mascort-Roca3, Francisco Javier Amador-Romero4, Begoña Bellas-Beceiro5, Joan Clofent-Vilaplana6, Sabela Carballal7, Juan Ferrándiz-Santos8, Antonio Z Gimeno-García9, Rodrigo Jover10, Carolina Mangas-Sanjuán10, Leticia Moreira7, María Pellisè7, Enrique Quintero9, Elena Rodríguez-Camacho11, Pablo Vega-Villaamil12.   

Abstract

This document updates the recommendations made by the Spanish Society of Family and Community Medicine and the Spanish Association of Gastroenterology for the diagnosis and prevention of colorectal cancer (CRC). In order to evaluate the quality of the evidence and determine the recommendation levels of the interventions, we used the Grading of Recommendations, Assessment, Development and Evaluation (GRADE) methodology. This document establishes optimal delay intervals based on symptoms and the faecal immunochemical test (FIT) and recommends reducing the barriers for diagnostic confirmation in symptomatic subjects. With regard to CRC screening in the average-risk population, we propose strategies to achieve the universal implementation of organised CRC screening programmes based on biennial FIT and to increase the participation of the target population, including the involvement of Primary Healthcare. This Clinical Practice Guideline recommends universal screening for Lynch syndrome with mismatch repair proteins immunohistochemistry or microsatellite instability in incident CRCs and the use of gene panels in patients with adenomatous polyposis. It also updates the strategies to reduce the incidence and mortality of both CRC and other tumours associated with hereditary syndromes. Regarding non-hereditary familial CRC and surveillance after resection of adenomas, serrated lesions or CRC, we established the recommendations based on the attributable risk and the risk reduction of the proposed intervention. Finally, the document includes recommendations regarding surveillance intervals in inflammatory bowel disease and the attitude towards dysplasia.
Copyright © 2018 Elsevier España, S.L.U. All rights reserved.

Entities:  

Keywords:  Clinical Practice Guideline; Colonoscopia; Colonoscopy; Colorectal cancer; Cribado poblacional; Cáncer colorrectal; Diagnosis; Diagnóstico; Enfermedad inflamatoria intestinal; Faecal occult blood test; Guía de práctica clínica; Inflammatory bowel disease; Lynch syndrome; Poliposis; Polyposis; Population screening; Prevención; Prevention; Síndrome de Lynch; Test de sangre oculta en heces

Mesh:

Year:  2018        PMID: 30245076     DOI: 10.1016/j.gastrohep.2018.07.012

Source DB:  PubMed          Journal:  Gastroenterol Hepatol        ISSN: 0210-5705            Impact factor:   2.102


  9 in total

1.  Accuracy of blood-based biomarkers for screening precancerous colorectal lesions: a protocol for systematic review and meta-analysis.

Authors:  Timothy J H Lathlean; Molla M Wassie; Jean M Winter; Rishabh Goyal; Graeme P Young; Erin L Symonds
Journal:  BMJ Open       Date:  2022-05-30       Impact factor: 3.006

2.  Factors Associated with Colorectal Cancer Screening in Spain: Results of the 2017 National Health Survey.

Authors:  Rauf Nouni-García; Ángela Lara-López; Concepción Carratalá-Munuera; Vicente F Gil-Guillén; Adriana López-Pineda; Domingo Orozco-Beltrán; Jose A Quesada
Journal:  Int J Environ Res Public Health       Date:  2022-04-29       Impact factor: 4.614

Review 3.  Diagnosis, epidemiology and management of serrated polyposis syndrome: a comprehensive review of the literature.

Authors:  Fotios S Fousekis; Ioannis V Mitselos; Dimitrios K Christodoulou
Journal:  Am J Transl Res       Date:  2021-06-15       Impact factor: 4.060

4.  Faecal immunochemical test to triage patients with abdominal symptoms for suspected colorectal cancer in primary care: review of international use and guidelines.

Authors:  Marije van Melle; Samir I S Yep Manzano; Hugh Wilson; Willie Hamilton; Fiona M Walter; Sarah E R Bailey
Journal:  Fam Pract       Date:  2020-10-19       Impact factor: 2.267

5.  Impact of the faecal immunochemical test on colorectal cancer survival.

Authors:  María Angeles Gutierrez-Stampa; Vanessa Aguilar; Cristina Sarasqueta; Joaquín Cubiella; Isabel Portillo; Luis Bujanda
Journal:  BMC Cancer       Date:  2020-07-01       Impact factor: 4.430

6.  Familial Colorectal Cancer and Genetic Susceptibility: Colorectal Risk Variants in First-Degree Relatives of Patients With Colorectal Cancer.

Authors:  Carla J Gargallo-Puyuelo; Ángel Lanas; Patricia Carrera-Lasfuentes; Ángel Ferrández; Enrique Quintero; Marta Carrillo; Inmaculada Alonso-Abreu; María Asunción García-González
Journal:  Clin Transl Gastroenterol       Date:  2021-02-03       Impact factor: 4.488

7.  In Vivo Evaluation of Sgc8-c Aptamer as a Molecular Imaging Probe for Colon Cancer in a Mouse Xenograft Model.

Authors:  Ana Paula Arévalo; Romina Castelli; Manuel Ibarra; Martina Crispo; Victoria Calzada
Journal:  Int J Mol Sci       Date:  2022-02-23       Impact factor: 5.923

8.  Combining faecal immunochemical testing with blood test results for colorectal cancer risk stratification: a consecutive cohort of 16,604 patients presenting to primary care.

Authors:  Diana R Withrow; Brian Shine; Jason Oke; Andres Tamm; Tim James; Eva Morris; Jim Davies; Steve Harris; James E East; Brian D Nicholson
Journal:  BMC Med       Date:  2022-03-15       Impact factor: 8.775

9.  Not so FAST. Commentary on the article "Appraisal of the faecal haemoglobin, age and sex test (FAST) score in assessment of patients with lower bowel symptoms: an observational study".

Authors:  Joaquín Cubiella
Journal:  BMC Gastroenterol       Date:  2020-07-20       Impact factor: 3.067

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.